These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 991147)
41. High-dose combination chemotherapy for acute nonlymphoblastic leukemia in adults. Glucksberg H; Cheever MA; Farewell VT; Fefer A; Sale GE; Thomas ED Cancer; 1981 Sep; 48(5):1073-81. PubMed ID: 7023650 [TBL] [Abstract][Full Text] [Related]
42. Treatment of acute nonlymphoblastic leukemia in children with a multiple-drug protocol. Haghbin M; Murphy ML; Tan CT Cancer; 1977 Oct; 40(4):1417-21. PubMed ID: 907961 [TBL] [Abstract][Full Text] [Related]
43. High-dose cytosine arabinoside, daunomycin and 6-thioguanine in relapsed or refractory acute nonlymphocytic leukemia. Garewal H; Durie BG; Greenberg B Oncology; 1987; 44(6):333-5. PubMed ID: 3684173 [TBL] [Abstract][Full Text] [Related]
45. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Yates JW; Wallace HJ; Ellison RR; Holland JF Cancer Chemother Rep; 1973; 57(4):485-8. PubMed ID: 4586956 [No Abstract] [Full Text] [Related]
46. The role of cytosine arabinoside maintenance in acute nonlymphoblastic leukemia. Grozea PN; Bottonley RH; Shaw MT; Tu H; Chanes RE; Condit PT Cancer; 1975 Sep; 36(3):855-60. PubMed ID: 1182675 [TBL] [Abstract][Full Text] [Related]
47. [Clinical and cell kinetic data on the combination of cytosine arabinoside with daunorubicin, isosfamide, thioguanine, and vincristine for remission induction and maintenance in patients with acute myelocytic leukaemia (author's transl)]. Büchner Th; Kamanabroo D; Urbanitz D; Hiddemann W; van de Loo J Blut; 1978 Jun; 36(6):372-6. PubMed ID: 274968 [TBL] [Abstract][Full Text] [Related]
48. Intensified remission induction therapy for acute nonlymphocytic leukemia (ANLL). Treatment report on 60 patients. Urbanitz D; Büchner T; Kamanabroo D; Hiddemann W; Schulte H; van de Loo J Blut; 1981 Aug; 43(2):129-33. PubMed ID: 7260406 [TBL] [Abstract][Full Text] [Related]
49. Combinations of arabinosyl cytosine and 6-thioguanine for treatment of adults with acute leukemia. Bodey GP; Freireich EJ; McCredie KB; Rodriguez V; Burgess MA; Frei E Med Pediatr Oncol; 1975; 1(1):29-35. PubMed ID: 1066520 [TBL] [Abstract][Full Text] [Related]
50. [Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine]. Büchner T; Kamanabroo D; Hiddemann W; Urbanitz D Verh Dtsch Ges Inn Med; 1978; (84):145-8. PubMed ID: 283634 [No Abstract] [Full Text] [Related]
51. Vincristine (NSC-67574), cytosine arabinoside (NSC-63878), 6 thioguanine (NSC-752) and daunorubicin (NSC-82151) (VAT-D): a pilot study of combination chemotherapy for remission induction in acute myeloid leukemia in adults. Sartiano GP; Pfrimmer WJ; Turner AR Med Pediatr Oncol; 1978; 4(3):205-12. PubMed ID: 277748 [TBL] [Abstract][Full Text] [Related]
52. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia. Carey RW; Ribas-Mundo M; Ellison RR; Glidewell O; Lee ST; Cuttner J; Levy RN; Silver R; Blom J; Haurani F; Spurr CL; Harley JB; Kyle R; Moon JH; Eagan RT; Holland JH Cancer; 1975 Nov; 36(5):1560-6. PubMed ID: 1059499 [TBL] [Abstract][Full Text] [Related]
53. [Treatment of acute myeloid leukaemia in adults with cytarabine and thioguanine]. Fülle HH; Pribilla W Dtsch Med Wochenschr; 1972 May; 97(18):711-7. PubMed ID: 4502483 [No Abstract] [Full Text] [Related]
54. Further local experience in the treatment of acute non-lymphoblastic leukaemia. Bezwoda WR; Baynes RD; Hougaard M; Derman DP; Bothwell TH; Katz J S Afr Med J; 1978 Dec; 54(24):1011-4. PubMed ID: 746438 [TBL] [Abstract][Full Text] [Related]